Display options
Share it on

Endocrine. 1996 Oct;5(2):199-204. doi: 10.1007/BF02738707.

Effects of streptozotocin-induced diabetes on the response of male rats to immobilization stress.

Endocrine

T R McCovery, C Fadden, R W Steger

Affiliations

  1. Department of Physiology, SIU School of Medicine, 62901-6512, Carbondale, IL.

PMID: 21153112 DOI: 10.1007/BF02738707

Abstract

The effects of streptozotocin-induced (STZ) diabetes on the response to immobilization stress were evaluated in adult male rats. Rats were injected with STZ or vehicle and handled daily to minimize stress. Four weeks later, half of the animals were lightly anesthetized with ether and immobilized for 20 min. At that time the stressed and nonstressed controls were sacrificed, and blood and tissue collected for hormone and amine determinations. Immobilization caused an increase in plasma glucose levels in the controls, but caused no further increase in the already high levels seen in the diabetic rats. Basal corticosterone levels did not differ between the STZ and control rats, and the increase after immobilization was of similar magnitude. The stress-induced increase in prolactin was attenuated in the diabetic rats. Immobilization caused a significant rise in plasma norepinephrine (NE) levels in control, but not in diabetic rats. Adrenal NE content and tyrosine hydroxylase activity were not significantly affected by stress or STZ treatment. Dopamine (DA) and NE content was increased in the hypothalamus of immobilized diabetic rats as compared to nondiabetic immobilized controls. These results demonstrate that diabetic rats respond to immobilization stress, but the endocrine and sympathetic nervous system response is impaired. Changes in the stress response may be related to changes in hypothalamic amine metabolism.

References

  1. Horm Metab Res. 1977 Nov;9(6):469-73 - PubMed
  2. Endocrinology. 1991 Jul;129(1):99-108 - PubMed
  3. Physiol Behav. 1990 Feb;47(2):231-8 - PubMed
  4. Pharmacol Biochem Behav. 1980 Jul;13(1):129-31 - PubMed
  5. Diabet Med. 1988 Jul-Aug;5(5):469-73 - PubMed
  6. Physiol Behav. 1989 Mar;45(3):483-9 - PubMed
  7. Horm Res. 1987;25(4):206-14 - PubMed
  8. Behav Neural Biol. 1979 Nov;27(3):249-65 - PubMed
  9. Neuroendocrinology. 1983 Nov;37(5):361-70 - PubMed
  10. Diabetes Care. 1991 Mar;14(3):240-8 - PubMed
  11. Horm Metab Res. 1986 Jun;18(6):419-20 - PubMed
  12. Biol Reprod. 1987 Feb;36(1):138-47 - PubMed
  13. Diabet Med. 1991;8 Spec No:S58-62 - PubMed
  14. J Chromatogr. 1979 Jul 21;163(3):247-52 - PubMed
  15. Mol Cell Endocrinol. 1985 Dec;43(2-3):135-40 - PubMed
  16. Biochem Pharmacol. 1987 Apr 1;36(7):1011-6 - PubMed
  17. J Steroid Biochem. 1981 Dec;14(12):1279-84 - PubMed
  18. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1989;93(2):303-6 - PubMed
  19. Hypertension. 1983 Jul-Aug;5(4):552-9 - PubMed
  20. Endocrinology. 1974 Sep;95(3):760-5 - PubMed
  21. Clin Sci (Lond). 1991 Jan;80(1):53-8 - PubMed
  22. J Endocrinol Invest. 1988 Dec;11(11):817-29 - PubMed
  23. Endocrinology. 1989 Apr;124(4):1737-43 - PubMed
  24. Diabetes. 1990 Aug;39(8):942-8 - PubMed
  25. Neuroendocrinology. 1985 Jul;41(1):64-71 - PubMed
  26. Diabetologia. 1979 Apr;16(4):211-24 - PubMed
  27. Diabetes. 1983 Jan;32(1):55-60 - PubMed
  28. Life Sci. 1984 Sep 3;35(10):1077-81 - PubMed
  29. Life Sci. 1991;48(9):887-91 - PubMed
  30. Diabetes. 1993 Jun;42(6):862-8 - PubMed

Publication Types